A Randomized, Multicentre, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Oesophageal or Gastroesophageal Junction Cancer

Strickland, Andrew (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

NMA Reference Number: HREC/16/MonH/118
Monash Health HREC Ref: 16208A

Status	Active
Effective start/end date	8/02/19 → 27/09/26

Clinical Trial Phase

Phase III (a & b)